Unique ID issued by UMIN | UMIN000001026 |
---|---|
Receipt number | R000001237 |
Scientific Title | The effects of high molecular weight sodium hyaluronate on JKOM score and urine CTX-2 concentration -A randomized comparative clinical study with loxoprofen as a control drug- |
Date of disclosure of the study information | 2008/02/13 |
Last modified on | 2014/03/15 11:38:55 |
The effects of high molecular weight sodium hyaluronate on JKOM score and urine CTX-2 concentration -A randomized comparative clinical study with loxoprofen as a control drug-
OA Study
The effects of high molecular weight sodium hyaluronate on JKOM score and urine CTX-2 concentration -A randomized comparative clinical study with loxoprofen as a control drug-
OA Study
Japan |
Osteoarthrities
Orthopedics |
Others
NO
To elucidate the efficacy and safety of sodium hyaluronate on JKOM score as a primary endpoint by comparing with loxoprofen in patients with osteoarthritis of the knee.
Safety,Efficacy
Change of JKOM score from baseline.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Medicine |
Sodium hyaluronate : Suvenyl; intra-articular injection 25mg
Loxoprofen : Roxonin; tablet 60mg
50 | years-old | <= |
80 | years-old | > |
Male and Female
;Ambulatory outpatients with knee pain, between the ages of 50 and 80
;Regardless of gender, but in case of female, only postmenopausal patients
;Mild to moderate OA of the knee with Kellgren-Lawrence (K-L) grade of between land3
;Patients who signed informed consent documents for the treatment and investigation protocol
;Taken glucocorticoids (intra-articular injection, oral use, external use) within previous 4weeks
;Taken NSAIDs (oral, suppository, external) within previous 2weeks
;K-L grade of contralateral knee is 4
;Secondary OA of the knee (eg. traumatic OA of the knee)
;Patellofemoral OA (K-L grade of more than 3)
;Moderate OA other than knee
;Rheumatoid arthritis
;Having history of total knee replacement or total hip replacement
;Having history of anaphylactoid reaction to sodium hyaluronan or loxoprofene
;Peptic ulcer
;Abnormal dysemia, abnormal hepatic function, abnormal kidney function, abnormal heart function
;Aspirin-induced asthma or its history
;.Inappropriate patients from the doctor's viewpoint
300
1st name | |
Middle name | |
Last name | Toshitaka Nakamura |
University of occupational and Environmental Health
Orthopaedic Surgery.
address:1-1, Iseigaoka, Yahata-nishi-ku, Kitakyushu, Fukuoka, 807-8555
1st name | |
Middle name | |
Last name | Kunihiko Hayashi |
central cordinating center
Gunma univercity
Showamachi, Maebashi, Gunma 371-8514, Japan
027-220-8974
knee@gunma-rct.com
Research Group of Cartilage Metabolism
none
Self funding
NO
2008 | Year | 02 | Month | 13 | Day |
Published
http://arthritis-research.com/content/16/1/R18
The early efficacy of IA-HA was not inferior to that of NSAIDs, and the safety of early-phase of IA-HA was superior to that of NSAIDs for patients with knee OA.
Completed
2008 | Year | 01 | Month | 01 | Day |
2008 | Year | 02 | Month | 01 | Day |
2010 | Year | 03 | Month | 01 | Day |
2008 | Year | 02 | Month | 12 | Day |
2014 | Year | 03 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001237
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |